Note: Ingredients listed on restricted chemical lists
EC/CAS
104653-34-1
Name of the chemical
Difethialon (ISO); 3-[3-(4′-Brombiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1- yl]-4-hydroxy-2H-1-benzothiopyran-2-on (2016/1179)
Concentration
N/A
General Information
Revision date
2018-01-08
Product name
RODILON BLOCK
CAS No.
104653-34-1
supplier name
Bayer Environmental Science
Emergency telephone
00800 1020 3333 (24 hr
Icons in SDS
Company Information
company name
Bayer Environmental Science
e-mail address of the competent person responsible for the Safety Data Sheet
ukinfo@bayercropscience.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373, H412
Hazard statements
Code
Statements
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
2.1 Classification of the substance or mixture
Classification in accordance with Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures, as amended. Specific target organ toxicity - repeated exposure: Category 2 H373 May cause damage to organs (Blood) through prolonged or repeated exposure. Chronic aquatic toxicity: Category 3 H412 Harmful to aquatic life with long lasting effects.
2.2 Label elements
Labelling in accordance with Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures, as amended. Hazard label for supply/use required.
Hazardous Ingredients
Difethialone
Hazard statements
H373 May cause damage to organs (Blood) through prolonged or repeated exposure. H412 Harmful to aquatic life with long lasting effects. EUH401 To avoid risks to human health and the environment, comply with the instructions for use.
Precautionary statements
P273 Avoid release to the environment. P314 Get medical advice/ attention if you feel unwell. P501 Dispose of contents/container to a licensed hazardous-waste disposal contractor or collection site except for empty clean containers which can be disposed of as non- hazardous waste.
2.3 Other hazards
Because of antivitamin K properties of the active ingredient, absorption can inhibit blood coagulation and cause haemorrhagic syndrome.
